Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 20 | 5 | 450 | 40 | 0 |
| Cost of Goods | 3 | 1 | 20 | 40 | 0 |
| Gross Profit | 20 | 4 | 430 | 8 | 0 |
| Operating Expenses | 15,323 | 17,711 | 23,970 | 13,010 | 10,090 |
| Operating Income | -15,303 | -17,706 | -23,520 | -12,970 | -10,090 |
| Interest Expense | 770 | 230 | 0 | 0 | 0 |
| Other Income | 323 | 406 | 920 | 840 | 1,280 |
| Pre-tax Income | -15,750 | -17,530 | -22,600 | -12,130 | -8,810 |
| Net Income Continuous | 15,258 | -22,062 | -22,605 | -10,929 | -8,605 |
| Net Income | $-15,750 | $-17,530 | $-22,600 | $-12,130 | $-8,810 |
| EPS Basic Total Ops | 14,607.56 | -21,100.26 | -702.62 | -12,984.50 | -9,738.37 |
| EPS Basic Continuous Ops | 13,870.91 | -20,056.36 | -710.85 | -12,143.33 | -9,561.11 |
| EPS Diluted Total Ops | 14,607.56 | -21,100.26 | -702.62 | -12,984.50 | -9,738.37 |
| EPS Diluted Continuous Ops | 13,870.91 | -20,056.36 | -710.85 | -12,143.33 | -9,561.11 |
| EBITDA(a) | $-14,083 | $-16,746 | $-23,110 | $-12,590 | $-9,460 |